Dihomo-γ-Linolenoyl Ethanolamide

Dihomo-γ-Linolenoyl Ethanolamide, an endocannabinoid, is a cannabinoid (CB) receptor agonist with Kis of 857 nM and 598 nM for human recombinant CB1 and CB2 receptors, respectively[1].

Product Specifications

CAS Number

[150314-34-4]

UNSPSC

12352211

Target

Cannabinoid Receptor; Endogenous Metabolite

Type

Reference compound

Related Pathways

GPCR/G Protein; Metabolic Enzyme/Protease; Neuronal Signaling

Applications

Metabolism-protein/nucleotide metabolism

Field of Research

Neurological Disease

Assay Protocol

https://www.medchemexpress.com/dihomo-γ-linolenoyl-ethanolamide.html

Concentration

71.52 mM * 200 μL in Ethanol

Purity

99.9

Solubility

10 mM in DMSO

Smiles

CCCCC/C=C\C/C=C\C/C=C\CCCCCCC(NCCO)=O

Molecular Formula

C22H39NO2

Molecular Weight

349.55

References & Citations

[1]C C Felder, et al. Comparison of the pharmacology and signal transduction of the human cannabinoid CB1 and CB2 receptors. Mol Pharmacol. 1995 Sep;48 (3) :443-50.